Literature DB >> 25596268

BCOR and BCORL1 mutations in pediatric acute myeloid leukemia.

Jasmijn D E de Rooij1, Marry M van den Heuvel-Eibrink1, Malou C H Hermkens1, Lonneke J Verboon1, Susan T C J M Arentsen-Peters1, Maarten Fornerod1, Andre Baruchel2, Jan Stary3, Dirk Reinhardt4, Valerie de Haas5, Rob Pieters6, C Michel Zwaan7.   

Abstract

Entities:  

Keywords:  BCOR; BCOR1; clinical outcome; mutations; pediatric AML

Mesh：

Substances：

Year:  2015        PMID： 25596268      PMCID： PMC4420230          DOI： 10.3324/haematol.2014.117796

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  Biology, risk stratification, and therapy of pediatric acute leukemias: an update.

Authors:  Ching-Hon Pui; William L Carroll; Soheil Meshinchi; Robert J Arceci
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

2.  Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.

Authors:  Christine J Harrison; Robert K Hills; Anthony V Moorman; David J Grimwade; Ian Hann; David K H Webb; Keith Wheatley; Siebold S N de Graaf; Eva van den Berg; Alan K Burnett; Brenda E S Gibson
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

3.  Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.

Authors:  Christine von Neuhoff; Dirk Reinhardt; Annette Sander; Martin Zimmermann; Jutta Bradtke; David R Betts; Zuzana Zemanova; Jan Stary; Jean-Pierre Bourquin; Oskar A Haas; Michael N Dworzak; Ursula Creutzig
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

4.  Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.

Authors:  Iris H I M Hollink; Marry M van den Heuvel-Eibrink; Susan T C J M Arentsen-Peters; Martin Zimmermann; Justine K Peeters; Peter J M Valk; Brian V Balgobind; Edwin Sonneveld; Gertjan J L Kaspers; Eveline S J M de Bont; Jan Trka; Andre Baruchel; Ursula Creutzig; Rob Pieters; Dirk Reinhardt; C Michel Zwaan
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

5.  Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.

Authors:  Brian V Balgobind; Iris H I M Hollink; Susan T C J M Arentsen-Peters; Martin Zimmermann; Jochen Harbott; H Berna Beverloo; Anne R M von Bergh; Jacqueline Cloos; Gertjan J L Kaspers; Valerie de Haas; Zuzana Zemanova; Jan Stary; Jean-Michel Cayuela; Andre Baruchel; Ursula Creutzig; Dirk Reinhardt; Rob Pieters; C Michel Zwaan; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

6.  BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.

Authors:  Frederik Damm; Virginie Chesnais; Yasunobu Nagata; Kenichi Yoshida; Laurianne Scourzic; Yusuke Okuno; Raphael Itzykson; Masashi Sanada; Yuichi Shiraishi; Véronique Gelsi-Boyer; Aline Renneville; Satoru Miyano; Hiraku Mori; Lee-Yung Shih; Sophie Park; François Dreyfus; Agnes Guerci-Bresler; Eric Solary; Christian Rose; Stéphane Cheze; Thomas Prébet; Norbert Vey; Marion Legentil; Yannis Duffourd; Stéphane de Botton; Claude Preudhomme; Daniel Birnbaum; Olivier A Bernard; Seishi Ogawa; Michaela Fontenay; Olivier Kosmider
Journal:  Blood       Date:  2013-09-18       Impact factor: 22.113

7.  NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.

Authors:  J D E de Rooij; I H I M Hollink; S T C J M Arentsen-Peters; J F van Galen; H Berna Beverloo; A Baruchel; J Trka; D Reinhardt; E Sonneveld; M Zimmermann; T A Alonzo; R Pieters; S Meshinchi; M M van den Heuvel-Eibrink; C Michel Zwaan
Journal:  Leukemia       Date:  2013-03-27       Impact factor: 11.528

Review 8.  Pediatric acute myeloid leukemia: towards high-quality cure of all patients.

Authors:  Gertjan J L Kaspers; Christian M Zwaan
Journal:  Haematologica       Date:  2007-11       Impact factor: 9.941

9.  Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML.

Authors:  I H I M Hollink; C M Zwaan; M Zimmermann; T C J M Arentsen-Peters; R Pieters; J Cloos; G J L Kaspers; S S N de Graaf; J Harbott; U Creutzig; D Reinhardt; M M van den Heuvel-Eibrink; C Thiede
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

10.  Ensembl 2014.

Authors:  Paul Flicek; M Ridwan Amode; Daniel Barrell; Kathryn Beal; Konstantinos Billis; Simon Brent; Denise Carvalho-Silva; Peter Clapham; Guy Coates; Stephen Fitzgerald; Laurent Gil; Carlos García Girón; Leo Gordon; Thibaut Hourlier; Sarah Hunt; Nathan Johnson; Thomas Juettemann; Andreas K Kähäri; Stephen Keenan; Eugene Kulesha; Fergal J Martin; Thomas Maurel; William M McLaren; Daniel N Murphy; Rishi Nag; Bert Overduin; Miguel Pignatelli; Bethan Pritchard; Emily Pritchard; Harpreet S Riat; Magali Ruffier; Daniel Sheppard; Kieron Taylor; Anja Thormann; Stephen J Trevanion; Alessandro Vullo; Steven P Wilder; Mark Wilson; Amonida Zadissa; Bronwen L Aken; Ewan Birney; Fiona Cunningham; Jennifer Harrow; Javier Herrero; Tim J P Hubbard; Rhoda Kinsella; Matthieu Muffato; Anne Parker; Giulietta Spudich; Andy Yates; Daniel R Zerbino; Stephen M J Searle
Journal:  Nucleic Acids Res       Date:  2013-12-06       Impact factor: 16.971
View more
  8 in total

1.  A Case Series of BCOR Sarcomas With a New Splice Variant of BCOR/CCNB3 Fusion Gene.

Authors:  Anastasios Kyriazoglou; Natalia Tourkantoni; Michalis Liontos; Flora Zagouri; Louisa Mahaira; Alexandra Papakosta; Dimitra Michali; Amalia Patereli; Kalliopi Stefanaki; Vasiliki Tzotzola; Evangelia Skoura; Margarita Baka; Sofia Polychronopoulou; Antonis Kattamis; Efthymios Dimitriadis
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 2.  BCOR gene alterations in hematologic diseases.

Authors:  Paolo Sportoletti; Daniele Sorcini; Brunangelo Falini
Journal:  Blood       Date:  2021-12-16       Impact factor: 22.113

3.  Case of aggressive metastatic follicular variant papillary thyroid carcinoma with BRAF K601E and BCORL1 mutations.

Authors:  Doaa Attia; Alexander Lurie; Qihui Zhai; Thomas Mesko; Robert Smallridge
Journal:  BMJ Case Rep       Date:  2020-06-30

4.  BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma.

Authors:  Guozhi Yin; Zhikui Liu; Yufeng Wang; Changwei Dou; Chao Li; Wei Yang; Yingmin Yao; Qingguang Liu; Kangsheng Tu
Journal:  BMC Cancer       Date:  2016-02-15       Impact factor: 4.430

Review 5.  BCOR involvement in cancer.

Authors:  Annalisa Astolfi; Michele Fiore; Fraia Melchionda; Valentina Indio; Salvatore N Bertuccio; Andrea Pession
Journal:  Epigenomics       Date:  2019-05-31       Impact factor: 4.778

Review 6.  Murine Models of Acute Myeloid Leukemia.

Authors:  Kristen J Kurtz; Shannon E Conneely; Madeleine O'Keefe; Katharina Wohlan; Rachel E Rau
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

7.  Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.

Authors:  Paolo Sportoletti; Daniele Sorcini; Anna G Guzman; Jaime M Reyes; Arianna Stella; Andrea Marra; Sara Sartori; Lorenzo Brunetti; Roberta Rossi; Beatrice Del Papa; Francesco Maria Adamo; Giulia Pianigiani; Camilla Betti; Annarita Scialdone; Valerio Guarente; Giulio Spinozzi; Valentina Tini; Maria Paola Martelli; Margaret A Goodell; Brunangelo Falini
Journal:  Leukemia       Date:  2020-11-06       Impact factor: 11.528

8.  Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study.

Authors:  Stuart L Cramer; Aubrey L Miller; Joseph G Pressey; Tracy L Gamblin; Elizabeth A Beierle; Brian D Kulbersh; Patrick L Garcia; Leona N Council; Rupa Radhakrishnan; Skyler V Hendrix; David R Kelly; Raymond G Watts; Karina J Yoon
Journal:  Front Oncol       Date:  2018-01-11       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.